Suppr超能文献

5-羟色胺-mGlu2/3 受体复合物在大鼠脊髓谷氨酸能神经末梢:5-羟色胺到 mGlu2/3 的信号放大谷氨酸囊泡外排的自身控制的突触前机制。

5-HT-mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT to mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis.

机构信息

Department of Pharmacy, DiFAR, Pharmacology and Toxicology Section, Viale Cembrano 4, 16148, Genoa, Italy.

Department of Pharmacy, DiFAR, Pharmacology and Toxicology Section, Viale Cembrano 4, 16148, Genoa, Italy; Center of Excellence for Biomedical Research, University of Genoa, Viale Benedetto XV, 16132, Genoa, Italy.

出版信息

Neuropharmacology. 2018 May 1;133:429-439. doi: 10.1016/j.neuropharm.2018.02.030. Epub 2018 Feb 27.

Abstract

Presynaptic mGlu2/3 autoreceptors exist in rat spinal cord nerve terminals as suggested by the finding that LY379268 inhibited the 15 mM KCl-evoked release of [H]D-aspartate ([H]D-Asp) in a LY341495-sensitive manner. Spinal cord glutamatergic nerve terminals also possess presynaptic release-regulating 5-HT heteroreceptors. Actually, the 15 mM KCl-evoked [H]D-Asp exocytosis from spinal cord synaptosomes was reduced by the 5-HT agonist (±)DOI, an effect reversed by the 5-HT antagonists MDL11,939, MDL100907, ketanserin and trazodone (TZD). We investigated whether mGlu2/3 and 5-HT receptors colocalize and cross-talk in these terminals and if 5-HT ligands modulate the mGlu2/3-mediated control of glutamate exocytosis. Western blot analysis and confocal microscopy highlighted the presence of mGlu2/3 and 5-HT receptor proteins in spinal cord VGLUT1 positive synaptosomes, where mGlu2/3 and 5-HT receptor immunoreactivities largely colocalize. Furthermore, mGlu2/3 immunoprecipitates from spinal cord synaptosomes were also 5-HT immunopositive. Interestingly, the 100 pM LY379268-induced reduction of the 15 mM KCl-evoked [H]D-Asp overflow as well as its inhibition by 100 nM (±)DOI became undetectable when the two agonists were concomitantly added. Conversely, 5-HT antagonists (MDL11,939, MDL100907, ketanserin and TZD) reinforced the release-regulating activity of mGlu2/3 autoreceptors. Increased expression of mGlu2/3 receptor proteins in synaptosomal plasmamembranes paralleled the gain of function of the mGlu2/3 autoreceptors elicited by 5-HT antagonists. Based on these results, we propose that in spinal cord glutamatergic terminals i) mGlu2/3 and 5-HT receptors colocalize and interact one each other in an antagonist-like manner, ii) 5-HT antagonists are indirect positive allosteric modulator of mGlu2/3 autoreceptors controlling glutamate exocytosis.

摘要

突触前 mGlu2/3 自身受体存在于大鼠脊髓神经末梢,这一发现表明 LY379268 以 LY341495 敏感的方式抑制 15mM KCl 诱导的 [H]D-天冬氨酸 ([H]D-Asp) 的释放。脊髓谷氨酸能神经末梢还具有突触前释放调节 5-HT 异受体。实际上,5-HT 激动剂(±)DOI 可减少脊髓突触小体 15mM KCl 诱导的 [H]D-Asp 胞吐作用,该作用可被 5-HT 拮抗剂 MDL11,939、MDL100907、酮色林和曲唑酮 (TZD) 逆转。我们研究了 mGlu2/3 和 5-HT 受体是否在这些末梢中存在共定位和串扰,以及 5-HT 配体是否调节 mGlu2/3 介导的谷氨酸胞吐作用的控制。Western blot 分析和共聚焦显微镜强调了 mGlu2/3 和 5-HT 受体蛋白在脊髓 VGLUT1 阳性突触小体中的存在,其中 mGlu2/3 和 5-HT 受体免疫反应性大量共定位。此外,脊髓突触小体的 mGlu2/3 免疫沉淀物也为 5-HT 阳性。有趣的是,当两种激动剂同时添加时,100pM LY379268 诱导的 15mM KCl 诱导的 [H]D-Asp 溢出减少及其被 100nM(±)DOI 抑制变得无法检测到。相反,5-HT 拮抗剂(MDL11,939、MDL100907、酮色林和曲唑酮)增强了 mGlu2/3 自身受体的释放调节活性。突触小体质膜中 mGlu2/3 受体蛋白的表达增加与 5-HT 拮抗剂引起的 mGlu2/3 自身受体功能获得相平行。基于这些结果,我们提出在脊髓谷氨酸能神经末梢中,i)mGlu2/3 和 5-HT 受体共定位并以拮抗剂样方式相互作用,ii)5-HT 拮抗剂是控制谷氨酸胞吐作用的 mGlu2/3 自身受体的间接正变构调节剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验